UCI Health Launches First-in-Human Trial Using Laser Light to Treat Inoperable Pancreatic Tumors
Source Summary
UCI Health is conducting a Phase I clinical trial using laser light to target localized but inoperable pancreatic tumors. The study aims to help patients achieve cancer-free status through this novel treatment approach.
Why it matters
This first-in-human trial represents a novel therapeutic approach for patients with inoperable pancreatic tumors, a population with limited treatment options.
